EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trophoblast cell-surface antigen 2 expression in digestive neoplasms: a promising target for antibody-drug conjugates

Jinru Yang iD, Fangyuan Zhang, Xing Cai, Zixuan Ding, Conghua Xie iD, Hong Qiu iD

The Oncologist · 2025

DOI: 10.1093/oncolo/oyaf320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Jinru Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University…. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Cell Adhesion Molecules, Immunoconjugates, Biomarkers, Tumor. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Wu Jieping Medical Foundation, Beijing life Qasis Public Service Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trophoblast cell-surface antigen 2 (Trop2), a transmembrane glycoprotein overexpressed in multiple cancers, plays crucial roles in tumor progression and therapy resistance, yet its expression patterns and clinical significance in digestive cancers remain incompletely characterized.

Methods

This retrospective study analyzed a consecutive cohort of 2370 patients with histologically confirmed digestive cancers (804 gastric [GC], 1,384 colorectal [CRC], and 182 pancreatic cancers [PC]). Comprehensive clinicopathological data were systematically collected. Trop2 expression was quantitatively evaluated by immunohistochemistry and classified into Trop2-negative, Trop2-low, and Trop2-high based on the product of staining intensity and the proportion of positive tumor cells. Statistical analyses included univariate and multivariate logistic regression were used to identify significant clinicopathological and molecular predictors of Trop2 expression patterns. Univariate and multivariate logistic regression analyses were used to explore the relationship between Trop2 expression status (positive [Trop2 intensity ≥ 2] vs. negative) and various clinicopathological features of different tumor types.

Results

Trop2 was widely expressed in digestive cancers, with highest prevalence in PC and GC. Multivariate analysis revealed distinct Trop2 expression patterns in gastrointestinal malignancies. At the pan-cancer level, Trop2 expression significantly correlated with tumor type, (signet ring cell carcinoma) SRCC, vascular invasion (VI) and perineural invasion. Notably, GC showed independent associations with SRCC and intestinal-type Lauren classification; CRC showed VI as the predominant factor associated with Trop2 expression; while PC demonstrated unique correlations with female sex and T1 stage. These findings highlight tumor-type specific regulation of Trop2, providing critical insights for prognostic assessment and targeted therapy.

Conclusion

Trop2 is a promising biomarker for tumor aggressiveness and a potential target for antibody-drug conjugates (ADCs) in digestive cancers, particularly in SRCC-rich, metastatic, and invasive subtypes. These findings provide strong rationale for stratifying patient populations in future clinical investigations of Trop2-directed ADC therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmCell Adhesion MoleculesImmunoconjugatesBiomarkers, TumorDigestive System NeoplasmsGastrointestinal NeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdult

Stichwörter der Autor:innen

antibody-drug conjugatedigestive tumortargeted therapytrophoblast cell-surface antigen 2

Substanzen

Antigens, NeoplasmTACSTD2 protein, humanCell Adhesion MoleculesImmunoconjugatesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
  • Department of Oncology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
  • The First School of Clinical Medicine of Lanzhou University, Lanzhou, Hubei 730000, P.R. China.
  • Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, Hubei 420071, P.R. China.

ORCID-Profile: Jinru Yang, Conghua Xie, Hong Qiu

Förderung

  • National Natural Science Foundation of China
  • Wu Jieping Medical Foundation
  • Beijing life Qasis Public Service Center

Zitieren

APA

Yang, J., Zhang, F., Cai, X., Ding, Z., Xie, C., & Qiu, H. (2025). Trophoblast cell-surface antigen 2 expression in digestive neoplasms: a promising target for antibody-drug conjugates. The Oncologist. https://doi.org/10.1093/oncolo/oyaf320

Vancouver

Yang J, Zhang F, Cai X, Ding Z, Xie C, Qiu H. Trophoblast cell-surface antigen 2 expression in digestive neoplasms: a promising target for antibody-drug conjugates. The Oncologist. 2025. doi:10.1093/oncolo/oyaf320

BibTeX
@article{Yang2025,
  author = {Yang, Jinru and Zhang, Fangyuan and Cai, Xing and Ding, Zixuan and Xie, Conghua and Qiu, Hong},
  title = {Trophoblast cell-surface antigen 2 expression in digestive neoplasms: a promising target for antibody-drug conjugates},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyaf320}
}
Kostenlos starten →